A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study

Michael D. Prados, Kathleen Lamborn, W. K.A. Yung, Kurt Jaeckle, H. Ian Robins, Minesh Mehta, Howard A. Fine, Patrick Y. Wen, Timothy Cloughesy, Susan Chang, M. Kelly Nicholas, David Schiff, Harry Greenberg, Larry Junck, Karen Fink, Ken Hess, John Kuhn

Research output: Contribution to journalArticlepeer-review

161 Scopus citations

Fingerprint Dive into the research topics of 'A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study'. Together they form a unique fingerprint.

Medicine & Life Sciences